DK0659079T3 - Transdermalt terapeutisk system med pentylentetrazol som aktivt stof. - Google Patents

Transdermalt terapeutisk system med pentylentetrazol som aktivt stof.

Info

Publication number: DK0659079T3
Authority: DK; Denmark
Prior art keywords: active substance; pentylenetetrazole; therapeutic system; transdermal therapeutic; pharmaceutic product
Prior art date: 1992-09-02

Application number

DK93919071.6T

Other languages

Danish (da)

English (en)

Inventor

Fritz Herrmann

Thomas Hille

Original Assignee

Lohmann Therapie Syst Lts

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-09-02

Filing date

1993-08-16

Publication date

1997-08-04

1993-08-16 Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts

1997-08-04 Application granted granted Critical

1997-08-04 Publication of DK0659079T3 publication Critical patent/DK0659079T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Cosmetics (AREA)

DK93919071.6T 1992-09-02 1993-08-16 Transdermalt terapeutisk system med pentylentetrazol som aktivt stof. DK0659079T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE4229230A DE4229230C2 (de)	1992-09-02	1992-09-02	Transdermales therapeutisches System mit Pentetrazol als Wirkstoff

Publications (1)

Publication Number	Publication Date
DK0659079T3 true DK0659079T3 (da)	1997-08-04

Family

ID=6467017

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK93919071.6T DK0659079T3 (da)	1992-09-02	1993-08-16	Transdermalt terapeutisk system med pentylentetrazol som aktivt stof.

Country Status (10)

Country	Link
US (1)	US5965155A (ja)
EP (1)	EP0659079B1 (ja)
JP (1)	JPH08501090A (ja)
AT (1)	ATE147983T1 (ja)
CA (1)	CA2143688A1 (ja)
DE (2)	DE4229230C2 (ja)
DK (1)	DK0659079T3 (ja)
ES (1)	ES2100559T3 (ja)
GR (1)	GR3023046T3 (ja)
WO (1)	WO1994005295A1 (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6682757B1 (en) *	2000-11-16	2004-01-27	Euro-Celtique, S.A.	Titratable dosage transdermal delivery system
US20040208917A1 (en) *	2003-04-16	2004-10-21	Wilfried Fischer	Transdermal systems for the release of clonidine
EP2946776A1 (de) *	2014-05-20	2015-11-25	LTS LOHMANN Therapie-Systeme AG	Transdermales therapeutisches System zur Abgabe von Amitriptylin

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3315272C2 (de) *	1983-04-27	1986-03-27	Lohmann Gmbh & Co Kg, 5450 Neuwied	Pharmazeutisches Produkt und Verfahren zu seiner Herstellung
JPS6122275A (ja) *	1984-07-11	1986-01-30	Ishikawajima Harima Heavy Ind Co Ltd	港湾等極狭域の操船援助方法
WO1986000814A1 (en) *	1984-07-24	1986-02-13	Key Pharmaceuticals, Inc.	Adhesive transdermal dosage layer
GB8521275D0 (en) *	1985-08-27	1985-10-02	Blass D H	Therapeutic composition
US4906488A (en) *	1987-05-01	1990-03-06	Arcade, Inc.	Modification of permeant
US5273757A (en) *	1987-09-01	1993-12-28	Lts Lohmann Therapie-Systeme Gmbh & Co. Kg	Apparatus for the delivery of substances, processes for the production thereof and use thereof
US5446070A (en) *	1991-02-27	1995-08-29	Nover Pharmaceuticals, Inc.	Compositions and methods for topical administration of pharmaceutically active agents
JP2681365B2 (ja) *	1988-04-11	1997-11-26	日東電工株式会社	経皮吸収性製剤及びその製法
DE4020144A1 (de) *	1990-06-25	1992-01-09	Lohmann Therapie Syst Lts	Pflaster mit hohem gehalt an weichmachenden inhaltsstoffen
DE4110027C2 (de) *	1991-03-27	1996-08-29	Lohmann Therapie Syst Lts	Verfahren zur Konfektionierung transdermaler therapeutischer Pflaster

1992
- 1992-09-02 DE DE4229230A patent/DE4229230C2/de not_active Expired - Fee Related
1993
- 1993-08-16 JP JP6506791A patent/JPH08501090A/ja not_active Withdrawn
- 1993-08-16 AT AT93919071T patent/ATE147983T1/de not_active IP Right Cessation
- 1993-08-16 CA CA002143688A patent/CA2143688A1/en not_active Abandoned
- 1993-08-16 ES ES93919071T patent/ES2100559T3/es not_active Expired - Lifetime
- 1993-08-16 EP EP93919071A patent/EP0659079B1/de not_active Expired - Lifetime
- 1993-08-16 DK DK93919071.6T patent/DK0659079T3/da active
- 1993-08-16 WO PCT/EP1993/002183 patent/WO1994005295A1/de active IP Right Grant
- 1993-08-16 DE DE59305285T patent/DE59305285D1/de not_active Expired - Fee Related
1997
- 1997-04-04 GR GR970400713T patent/GR3023046T3/el unknown
1998
- 1998-06-08 US US09/093,178 patent/US5965155A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DE4229230C2 (de)	1997-01-16
ES2100559T3 (es)	1997-06-16
EP0659079B1 (de)	1997-01-22
US5965155A (en)	1999-10-12
JPH08501090A (ja)	1996-02-06
GR3023046T3 (en)	1997-07-30
DE59305285D1 (de)	1997-03-06
ATE147983T1 (de)	1997-02-15
WO1994005295A1 (de)	1994-03-17
DE4229230A1 (de)	1994-03-03
EP0659079A1 (de)	1995-06-28
CA2143688A1 (en)	1994-03-17

Similar Documents

Publication	Publication Date	Title
UA41879C2 (uk)	2001-10-15	Засіб для лікування мотонейронових захворювань
BR9610838A (pt)	1999-12-21	Processo para tratar um indivìduo tendo uma condição patológica envolvendo neovascularização.
TR199900083T2 (xx)	1999-04-21	Klaritromisinin kristal bi�imi I.
CS553490A3 (en)	1992-04-15	Transdermal therapeutic system
BG101118A (en)	1998-04-30	Therapeutical compounds
RO116900B1 (ro)	2001-07-30	Derivaţi de dihidrobenzopiran, procedeu pentru prepararea acestora, intermediar pentru realizarea procedeului, compoziţie farmaceutică şi metodă de tratament
CS145091A3 (en)	1992-01-15	Isoxazole-4-carboxamides and amides of hydroxyalkylidene cyanacetic acid, medicaments comprising said compounds and their application
NO20012896L (no)	2001-08-14	Fremgangsmåte for behandling av cerebral ischemi og anvendelse av erytropoietin eller erytropoietinderivater forbehandling av cerebral ischemi
SV1995000007A (es)	1996-02-28	Derivados del acido micofenolico 5-substituidos.
DK0690851T3 (da)	1999-11-08	Guanidin-derivater, som er anvendelige til behandling
UA41355C2 (uk)	2001-09-17	Засіб для лікування нейро-сніду
NO934706D0 (no)	1993-12-20	Substituerte 4-fenyl-pyridoner og 4-fenyl-2-alkoksypyridiner
NO980317L (no)	1998-03-24	Anvendelse av Calendula-glykosider for behandling av psoriasis
DK71387A (da)	1987-08-25	Terapeutisk middel til behandling af psoriasis
ATE77230T1 (de)	1992-07-15	Melatoninhaltige mittel sowie deren verwendungen.
MY117381A (en)	2004-06-30	Use of 1-hydroxy-2-pyridone for the treatment of seborrheic dermatitis
EP0325129A3 (en)	1990-12-19	Disubstituted pyridines
DK0659079T3 (da)	1997-08-04	Transdermalt terapeutisk system med pentylentetrazol som aktivt stof.
YU13499A (sh)	2001-09-28	Primena 1-hidroksi-2-piridona za lečenje seboroitičnog dermatitisa
PL310950A1 (en)	1996-01-08	Novel imidazole quinoxalinones, method of obtaining them and their application
DK0719276T3 (da)	1998-08-10	Ïstradiolestre med stærk oral virkning samt farmaceutiske præparater med indhold deraf
IE870577L (en)	1987-09-25	Topical amide preparation
ES2129654T3 (es)	1999-06-16	Dosificacion directa del colesterol.
PT862433E (pt)	2003-01-31	Composicao farmaceutica espumante topica para o tratamento de dermatoses induzidas por pityrosporum oval
ES2190581T3 (es)	2003-08-01	2-aminotetralina opticamente activa, procedimiento para su preparacion y composiciones farmaceuticas que la contienen, activa en la prevencion y tratamiento de shock septico.